Literature DB >> 10801778

Overexpression of bamacan/SMC3 causes transformation.

G Ghiselli1, R V Iozzo.   

Abstract

Bamacan can occur in certain cell types as either a secreted proteoglycan assembled into basement membranes or as an intracellular protein known as structural maintenance of chromosome 3 (SMC3). To assess the role of this protein in tumorigenesis, we investigated whether induced overexpression of bamacan/SMC3 could transform normal fibroblasts. We generated a full-length cDNA encoding the entire mouse bamacan/SMC3 and demonstrated appropriate transcription and translation into a 146-kDa protein. All the NIH and Balb/c 3T3 murine fibroblasts overexpressing this bamacan/SMC3 transgene generated foci of transformation and acquired anchorage-independent growth. The increased levels of bamacan/SMC3 expression achieved in the transfected fibroblasts were the same as those detected in a series of spontaneously transformed murine and human colon carcinoma cells. Moreover, a 3-4-fold overexpression of bamacan/SMC3 was detected in approximately 70% of human colon carcinoma specimens from matched pairs (n = 19, p < 0.0002) and in a cohort of intestinal tumors from Apc-deficient Min/+ mice. These results support the concept that deregulated expression of bamacan/SMC3 is involved in cell transformation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801778     DOI: 10.1074/jbc.C000213200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Evidence that replication fork components catalyze establishment of cohesion between sister chromatids.

Authors:  D R Carson; M F Christman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

Review 2.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

3.  Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells.

Authors:  Rachael C Casey; Theodore R Oegema; Keith M Skubitz; Stefan E Pambuccian; Suzanne M Grindle; Amy P N Skubitz
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 4.  Terminal glycosylation and disease: influence on cancer and cystic fibrosis.

Authors:  T F Scanlin; M C Glick
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

Review 5.  Can corruption of chromosome cohesion create a conduit to cancer?

Authors:  Huiling Xu; Jonathan M Tomaszewski; Michael J McKay
Journal:  Nat Rev Cancer       Date:  2011-02-17       Impact factor: 60.716

6.  A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo.

Authors:  Mathias Vormehr; Katharina Reinhard; Renata Blatnik; Kathrin Josef; Jan David Beck; Nadja Salomon; Martin Suchan; Abderraouf Selmi; Fulvia Vascotto; Johannes Zerweck; Holger Wenschuh; Mustafa Diken; Sebastian Kreiter; Özlem Türeci; Angelika B Riemer; Ugur Sahin
Journal:  Oncoimmunology       Date:  2018-12-24       Impact factor: 8.110

7.  Hyperphosphorylation of HDAC2 promotes drug resistance in a novel dual drug resistant mouse melanoma cell line model: an in vitro study.

Authors:  Bhuvanesh Sukhlal Kalal; Prashant Kumar Modi; Mohd Altaf Najar; Santosh Kumar Behera; Dinesh Upadhya; Thottethodi Subrahmanya Keshava Prasad; Vinitha Ramanath Pai
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

8.  Human SMC2 protein, a core subunit of human condensin complex, is a novel transcriptional target of the WNT signaling pathway and a new therapeutic target.

Authors:  Verónica Dávalos; Lucía Súarez-López; Julio Castaño; Anthea Messent; Ibane Abasolo; Yolanda Fernandez; Angel Guerra-Moreno; Eloy Espín; Manel Armengol; Eva Musulen; Aurelio Ariza; Joan Sayós; Diego Arango; Simó Schwartz
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

9.  Matrix-dependent plasticity of the malignant phenotype of bladder cancer cells.

Authors:  Robert E Hurst; Kimberly D Kyker; Rebecca B Bonner; Ron D Bowditch; George P Hemstreet
Journal:  Anticancer Res       Date:  2003 Jul-Aug       Impact factor: 2.480

10.  Role of SMC1 in overcoming drug resistance in triple negative breast cancer.

Authors:  Sushma Yadav; Archana Sehrawat; Zeynep Eroglu; George Somlo; Robert Hickey; Sailee Yadav; Xueli Liu; Yogesh C Awasthi; Sanjay Awasthi
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.